Hemopexin from human plasma, >=95% (SDS-PAGE), lyophilized powder

Code: h9291-500ug D2-231

Not available outside of the UK & Ireland.

Application

Hemopexin from human plasma has been used S. aureus surface colonization assay. It has also been used to stimulate mixed lymphocyte cells to determine th...


read more

Your Price
£294.00 500UG

Not available outside of the UK & Ireland.

Application

Hemopexin from human plasma has been used S. aureus surface colonization assay. It has also been used to stimulate mixed lymphocyte cells to determine the biomarkers in acute rejection.

Biochem/physiol Actions

Hemopexin is an acute-phase protein that plays a major protective role against oxidative stress through its heme-scavenging activities. Hemopexin binds heme with high affinity and is critical for recycling the iron bound to heme molecules and for protecting against heme-induced cellular damage. Free heme, when released or lost from proteins like hemoglobin, can catalyze the formation of reactive oxygen species. Heme is lipophilic and interchelates into lipid membranes and participate in the formation of highly-toxic hydroxyl radicals. Hemopexin may also protect against the heme-mediated oxidation of LDL cholesterol. Hemopexin may also serve an anti-inflammatory role via the negative regulation of IL-6 and TNF-α secretion by activated macrophages.

General description

Hemopexin (HPX) is produced by cells of the central nervous system. It is a 60 kDa serum glycoprotein.

Packaging

500 µg in poly bottle

Physical form

Lyophilized powder containing sodium phosphate, NaCl, and KCl, pH 7.4

assay≥95% (SDS-PAGE)
biological sourcehuman plasma
formlyophilized powder
Gene Informationhuman ... HPX(3263)
mol wt~57 kDa
NCBI accession no.NP_000604
Quality Level100
storage temp.−20°C
technique(s)microbiological culture: suitable
Cas Number0009013-71-2
This product has met the following criteria: